Conditions: Open Angle Glaucoma Ocular Hypertension
Keywords: Glaucoma Ocular hypertension
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 161
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the long-term safety of SPARC0913. A multicenter, open label, non-randomized, uncontrolled, single group assignment, safety study of subjects with primary open angle glaucoma or ocular hypertension is planned. Subjects will receive study medication for a period of 24-weeks.

Detailed description:
This is a multicenter, open label, non-randomized, single-arm, extension safety study to evaluate the long-term safety of SPARC0913. Subjects who completed the prior evaluator-masked clinical non-inferiority Study participated in the current study.

Arms:
arm 1: None

Interventions: intervention 1: SPARC0913
Intervention descriptions: intervention 1: One drop of SPARC0913 in affected eye once daily for 24 weeks

Protocol document: